Q2 2024 Holdings
Filed 2024-08-13 | 3 holdings | $91.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $53.1M | 2,266,934 | 58.0% |
| Lyell Immunopharma Inc | COM | 55083R104 | $29.2M | 20,162,332 | 31.9% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $9.2M | 1,792,210 | 10.1% |